Based on this mechanism, plasma exchange represents a valid option for the treatment of EGPA patients, particularly those with elevated serum RF or IgE levels indicating the involvement of the humoral immune system. The gene discussed is IGHE; the disease is eosinophilic granulomatosis with polyangiitis.